Tag: Pharmaceutical market

In 2023, Americans spent nearly $38.6 billion on the diabetes and weight-loss drug semaglutide, making it the top-selling medication by consumer spending. The answer to what is America's best selling drug, however, depends on whether you measure by revenue, prescription volume, or a specific time frame, reflecting a dynamic and competitive market.

According to data from 2024, Merck's cancer drug Keytruda has claimed the top spot in global pharmaceutical sales, showcasing a significant shift in the market after years of AbbVie's Humira leading the pack. For those asking, 'What is the top selling drug in America?', the answer has become more complex, reflecting major changes driven by biosimilar competition, new drug classes, and shifting patient needs.

With global sales reaching nearly $29.5 billion in 2024, Merck's Keytruda has firmly held its position as the top earner in the pharmaceutical industry, making it the answer to the question: **What is the highest selling drug in the world?**. This cancer immunotherapy's continued success showcases the immense market power of advanced oncology treatments, especially as older blockbusters face new market dynamics.

According to the FDA, the brand-name prescription medication Vermox (mebendazole) was not removed from the U.S. market for safety or efficacy reasons, reassuring patients of its past effectiveness. The primary driver behind the question, 'Why was Vermox discontinued?', lies instead in a series of manufacturer business decisions and evolving market dynamics.